UA103781C2 - Спосіб виготовлення гранульованого препарату активних інгредієнтів та гранульоваий препарат, одержаний таким способом - Google Patents

Спосіб виготовлення гранульованого препарату активних інгредієнтів та гранульоваий препарат, одержаний таким способом Download PDF

Info

Publication number
UA103781C2
UA103781C2 UAA201105988A UAA201105988A UA103781C2 UA 103781 C2 UA103781 C2 UA 103781C2 UA A201105988 A UAA201105988 A UA A201105988A UA A201105988 A UAA201105988 A UA A201105988A UA 103781 C2 UA103781 C2 UA 103781C2
Authority
UA
Ukraine
Prior art keywords
active ingredients
granular
granular preparation
core
fact
Prior art date
Application number
UAA201105988A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Кристоф Лебон
Паскаль Сюпли
Original Assignee
Дебрежа Э Ассосье Фарма
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA103781(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дебрежа Э Ассосье Фарма filed Critical Дебрежа Э Ассосье Фарма
Publication of UA103781C2 publication Critical patent/UA103781C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Glanulating (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA201105988A 2008-11-14 2009-11-13 Спосіб виготовлення гранульованого препарату активних інгредієнтів та гранульоваий препарат, одержаний таким способом UA103781C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
PCT/FR2009/052180 WO2010055268A1 (fr) 2008-11-14 2009-11-13 Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus

Publications (1)

Publication Number Publication Date
UA103781C2 true UA103781C2 (uk) 2013-11-25

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105988A UA103781C2 (uk) 2008-11-14 2009-11-13 Спосіб виготовлення гранульованого препарату активних інгредієнтів та гранульоваий препарат, одержаний таким способом

Country Status (25)

Country Link
US (1) US20110280945A1 (cg-RX-API-DMAC7.html)
EP (1) EP2349226A1 (cg-RX-API-DMAC7.html)
JP (1) JP5608681B2 (cg-RX-API-DMAC7.html)
KR (1) KR101585705B1 (cg-RX-API-DMAC7.html)
CN (1) CN102223879A (cg-RX-API-DMAC7.html)
AR (1) AR074330A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009315449B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0916019A2 (cg-RX-API-DMAC7.html)
CA (1) CA2743753A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011001115A1 (cg-RX-API-DMAC7.html)
CO (1) CO6382108A2 (cg-RX-API-DMAC7.html)
CU (1) CU20110107A7 (cg-RX-API-DMAC7.html)
EA (1) EA201100757A1 (cg-RX-API-DMAC7.html)
FR (1) FR2938432B1 (cg-RX-API-DMAC7.html)
IL (1) IL212850A0 (cg-RX-API-DMAC7.html)
MA (1) MA32789B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011005072A (cg-RX-API-DMAC7.html)
NZ (1) NZ592857A (cg-RX-API-DMAC7.html)
PE (1) PE20110945A1 (cg-RX-API-DMAC7.html)
SG (1) SG195651A1 (cg-RX-API-DMAC7.html)
TN (1) TN2011000235A1 (cg-RX-API-DMAC7.html)
TW (1) TWI522113B (cg-RX-API-DMAC7.html)
UA (1) UA103781C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010055268A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103543B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers
KR20240157168A (ko) * 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
JP2002544220A (ja) * 1999-05-17 2002-12-24 デー.ベー.エフ. 植物物質を含有する顆粒及びその製造方法
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
NZ575171A (en) * 2006-08-31 2012-04-27 Aptalis Pharmatech Inc Drug delivery systems comprising solid solutions of weakly basic drugs
ES2403103T3 (es) * 2007-02-14 2013-05-14 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Agente dispersante para pigmento orgánico y su utilización
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
ZA201103543B (en) 2012-01-25
US20110280945A1 (en) 2011-11-17
EA201100757A1 (ru) 2011-12-30
FR2938432A1 (fr) 2010-05-21
CU20110107A7 (es) 2012-01-31
CN102223879A (zh) 2011-10-19
CO6382108A2 (es) 2012-02-15
JP2012508786A (ja) 2012-04-12
EP2349226A1 (fr) 2011-08-03
AU2009315449B2 (en) 2015-03-26
NZ592857A (en) 2013-07-26
MA32789B1 (fr) 2011-11-01
TWI522113B (zh) 2016-02-21
SG195651A1 (en) 2013-12-30
KR20110095888A (ko) 2011-08-25
PE20110945A1 (es) 2012-02-01
AR074330A1 (es) 2011-01-05
CA2743753A1 (fr) 2010-05-20
AU2009315449A1 (en) 2010-05-20
CL2011001115A1 (es) 2011-11-11
WO2010055268A1 (fr) 2010-05-20
IL212850A0 (en) 2011-07-31
JP5608681B2 (ja) 2014-10-15
BRPI0916019A2 (pt) 2015-11-10
KR101585705B1 (ko) 2016-01-15
TW201029667A (en) 2010-08-16
FR2938432B1 (fr) 2011-05-20
MX2011005072A (es) 2011-10-03
TN2011000235A1 (fr) 2012-12-17

Similar Documents

Publication Publication Date Title
EP2349217B1 (fr) Granulé d'acide gamma-hydroxybutyrique
CN101977593B (zh) 包含弱碱性药物以及有机酸的给药系统
CN101410094B (zh) 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
EP3981390B1 (en) Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
SK285300B6 (sk) Farmaceutická formulácia obsahujúca množinu liekových podjednotiek a spôsob jej výroby
KR101252863B1 (ko) 안정성이 향상된 고형 제제 및 그 제조 방법
AU2009315449B2 (en) Novel method for preparing granulates of active principles, and granulates obtained thereof
CA2897302C (en) Sustained release formulations of lorazepam
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
JP2019131615A (ja) 固形製剤
CN102397262A (zh) 阿莫西林缓释固体药物组合物及其制备方法
EP2352491A2 (fr) Granulés à base de plantes
WO2005016317A1 (en) Process for manufacture of extended release pellets containing diltiazem hci
HK40063013A (en) Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
MXPA06003040A (es) Proceso para la obtencion de esferas recubiertas de ketorolaco, composicion farmaceutica y uso.
HK1213770B (en) Sustained release formulations of lorazepam
MX2008009616A (en) Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
KR20150141383A (ko) 슈도에페드린을 함유하는 방출조절 펠렛 조성물